StockData
Stemtech Corp logo

Stemtech Corp (STEK) stock

STEKOTCWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 0/30
$0.00+0.00 (0.00%)

Close on Oct 19, 2026Market cap $296.22KP/E –Yield –

Stemtech free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Stemtech's free cash flow for the twelve months ending Sep 30, 2026 was -$650.12K. For fiscal 2025 it was -$483.58K.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$483.58K–
FY2024Dec 31, 2024-$601.20K–
FY2023Dec 31, 2023-$2.04M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ3 2026Sep 30, 2026-$296.39K-1286.9%
Q2 FY2026CQ2 2026Jun 30, 2026-$54.84K-173.2%
Q1 FY2026CQ1 2026Mar 31, 2026-$425.88K–
Q4 FY2025CQ4 2025Dec 31, 2025$127.00K–
Q3 FY2025CQ3 2025Sep 30, 2025$24.97K–
Q2 FY2025CQ2 2025Jun 30, 2025$74.95K–
Q1 FY2025CQ1 2025Mar 31, 2025-$710.51K-169.8%
Q4 FY2024CQ4 2024Dec 31, 2024-$270.92K–
Q3 FY2024CQ3 2024Sep 30, 2024-$1.17M–
Q2 FY2024CQ2 2024Jun 30, 2024-$176.36K–
Q1 FY2024CQ1 2024Mar 31, 2024$1.02M–

More Stemtech figures

See a number that looks wrong?